Physical activity and sedentary behavior measured objectively and subjectively in overweight and obese adults with schizophrenia or schizoaffective disorders.

Janney CA, Ganguli R, Tang G, Cauley JA, Holleman RG, Richardson CR, et al. Physical activity and sedentary behavior measured objectively and subjectively in overweight and obese adults with schizophrenia or schizoaffective disorders. J Clin Psychiatry. 2015;76(10):e1277-84. DOI: 10.4088/JCP.14m09330. PubMed PMID: 26528650.

Do advanced statistical techniques really help in the diagnosis of the metabolic syndrome in patients treated with second-generation antipsychotics?

Van Schependom J, Yu W, Gielen J, Laton J, De Keyser J, De Hert M, et al. Do advanced statistical techniques really help in the diagnosis of the metabolic syndrome in patients treated with second-generation antipsychotics?. J Clin Psychiatry. 2015;76(10):e1292-9. DOI: 10.4088/JCP.14m09367. PubMed PMID: 26528652.

How to best treat patients with schizophrenia and co-occurring alcohol use disorder.

Petrakis IL. How to best treat patients with schizophrenia and co-occurring alcohol use disorder. J Clin Psychiatry. 2015;76(10):e1338-9. DOI: 10.4088/JCP.14com09625. PubMed PMID: 26528664.

What is the right pharmacotherapy for alcohol use disorder in patients with schizophrenia?

Batki SL. What is the right pharmacotherapy for alcohol use disorder in patients with schizophrenia?. J Clin Psychiatry. 2015;76(10):e1336-7. DOI: 10.4088/JCP.14com09611. PubMed PMID: 26528663.

Differences in the burden of psychiatric comorbidity in MS vs the general population.

Marrie RA, Fisk JD, Tremlett H, Wolfson C, Warren S, Tennakoon A, et al. Differences in the burden of psychiatric comorbidity in MS vs the general population. Neurology. 2015;85(22):1972-9. DOI: 10.1212/WNL.0000000000002174. PubMed PMID: 26519542.

Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-response.

Conley RR, Tamminga CA, Kelly DL, Richardson CM. Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-response. Biol Psychiatry. 1999;46(1):73-7. PubMed PMID: 10394475.

Pathways to aggression in schizophrenia affect results of treatment.

Volavka J, Citrome L. Pathways to aggression in schizophrenia affect results of treatment. Schizophr Bull. 2011;37(5):921-9. DOI: 10.1093/schbul/sbr041. PubMed PMID: 21562140; PubMed Central PMCID: PMC3160235.

The effects of clozapine on tardive dyskinesia.

Lieberman JA, Saltz BL, Johns CA, Pollack S, Borenstein M, Kane J. The effects of clozapine on tardive dyskinesia. Br J Psychiatry. 1991;158:503-10. PubMed PMID: 1675900.

Antipsychotic prescribing practices in the Veterans Healthcare Administration--New York metropolitan region.

Weissman EM. Antipsychotic prescribing practices in the Veterans Healthcare Administration--New York metropolitan region. Schizophr Bull. 2002;28(1):31-42. PubMed PMID: 12047020.

Racial disparities in the use of second-generation antipsychotics for the treatment of schizophrenia.

Mallinger JB, Fisher SG, Brown T, Lamberti JS. Racial disparities in the use of second-generation antipsychotics for the treatment of schizophrenia. Psychiatr Serv. 2006;57(1):133-6. DOI: 10.1176/appi.ps.57.1.133. PubMed PMID: 16399976.